Monocanalicular Versus Bicanalicular Silicone Intubation for Nasolacrimal Duct Stenosis in Adults
Authors:
- Mohsen Bahmani KashkouliMKMohsen Bahmani Kashkouli
- Roxanne C. KempsterRKRoxanne C. Kempster
- Gavin D. GallowayGGGavin D. Galloway
- Bijan BeigiBBBijan Beigi
- 1 March 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 21 (2) , 142-147
Abstract
To compare the success rate of monocanalicular versus bicanalicular silicone intubation of incomplete nasolacrimal duct obstruction (nasolacrimal duct stenosis) in adults. In a retrospective, nonrandomized comparative case series, 48 eyes of 44 adult patients with nasolacrimal duct stenosis underwent endoscopic probing and either bicanalicular (BCI; n = 22 eyes) or monocanalicular (MCI; n = 26 eyes) nasolacrimal duct intubation under general anesthesia. “Complete success” was defined as complete disappearance of the symptoms, “partial success” as improvement with some residual symptoms, and “failure” as absence of improvement or worsening of symptoms at last follow-up. The last follow-up examination included diagnostic probing and irrigation if there was not complete success. Patient ages ranged from 31 to 90 years (mean, 69; SD, 11.5). Forty-five tubes were removed 6 to 17 weeks (mean, 9.1; SD, 3) after surgery. Premature tube dislocation and removal occurred in one eye with BCI and in two eyes with MCI. Follow-up ranged from 6 to 52 months (mean, 14.9; SD, 8.4). The complete success rate was nearly the same in eyes with MCI (16/26, 61.53%) and BCI (13/22, 59.09%). Partial success (MCI: 8/26, 30.76%; BCI: 1/22, 4.54%) and failure (MCI: 2/26, 7.69%; BCI: 8/22, 36.36%) were, however, significantly different (p = 0.010). Complications included 3 slit puncta with BCI and 4 temporary superficial punctuate keratopathy after MCI. MCI had virtually the same complete success rate as BCI, a higher partial success rate than BCI, and a lower failure rate than BCI in treatment of nasolacrimal duct stenosis in adults.Keywords
This publication has 18 references indexed in Scilit:
- Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?British Journal of Ophthalmology, 2003
- Silicone intubation for obstruction of the nasolacrimal duct in adultsActa Ophthalmologica Scandinavica, 1999
- Monocanalicular nasolacrimal duct intubationOphthalmology, 1998
- Monocanalicular nasolacrimal duct intubation11Bruno Fayet, MD, is the original patent owner of the Monoka and currently holds financial interests in this device. Jean-Antoine Bernard, MD, is a paid consultant for FCI, manufacturer of the Monoka. Michael Assouline, MD, PhD, has no financial interest in any of the devices cited in this letter.Ophthalmology, 1998
- Nasolacrimal intubation in adultsBritish Journal of Ophthalmology, 1998
- Industrial Forum – IndustrieforumOncology Research and Treatment, 1995
- Bicanalicular versus monocanalicular silicone intubation for nasolacrimal duct impatency in children: A comparative studyOrbit, 1993
- Silicone Intubation for the Treatment of Congenital Lacrimal Duct Obstruction: Successful Results Removing the Tubes after Six WeeksOphthalmology, 1988
- A Method of Securing Double Silicone Tube Intubation of the Lacrimonasal SystemArchives of Ophthalmology (1950), 1987
- Silicone Intubation for Partial and Total Nasolacrimal Duct Obstruction in AdultsOphthalmic Plastic & Reconstructive Surgery, 1985